Literature DB >> 11038117

In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters.

S Y Lin1, K S Chen, H H Teng, M J Li.   

Abstract

Three low-molecular weight polyesters, poly(L-lactic acid) (PLA), copoly(lactic acid/glycolic acid) (PLGA) and poly(delta-valerolactone) (PV), were used to prepare water-soluble sodium diclofenac-loaded microspheres by using the oil-in-oil (o/o) emulsification-solvent evaporation method. Their micromeritic and physicochemical properties, and degradation and dissolution behaviours were determined in vitro. The results indicate that high encapsulation efficiency and better monodispersity might be achieved by the o/o emulsification-solvent evaporation method, depending on the amount of drug loading used. The slower evaporation of organic solvent from the system during microencapsulation seemed to modify the crystallinity of drug and polyester in the microspheres, determined by powder x-ray diffractometry and differential scanning calorimetry. The in vitro degradation rate of all the microspheres in pH7.4 phosphate buffer solution showed first-order kinetics and ranked in the order of PLGA > PLA > PV microspheres. Furthermore, the first-order release rate was also found in all the microspheres after an initial drug burst and ranked in the order of PLGA> PLA > PV microspheres, too. The relationship between degradation and dissolution behaviours of these microspheres is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038117     DOI: 10.1080/026520400417630

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  8 in total

1.  Unimolecular Micelle-Based Hybrid System for Perivascular Drug Delivery Produces Long-Term Efficacy for Neointima Attenuation in Rats.

Authors:  Guojun Chen; Xudong Shi; Bowen Wang; Ruosen Xie; Lian-Wang Guo; Shaoqin Gong; K Craig Kent
Journal:  Biomacromolecules       Date:  2017-06-14       Impact factor: 6.988

2.  Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

Authors:  Elizabeth M Enlow; J Christopher Luft; Mary E Napier; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-01-25       Impact factor: 11.189

3.  Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.

Authors:  Meltem Cetin; Alptug Atila; Yucel Kadioglu
Journal:  AAPS PharmSciTech       Date:  2010-08-10       Impact factor: 3.246

4.  Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.

Authors:  B Chiang; Y C Kim; A C Doty; H E Grossniklaus; S P Schwendeman; M R Prausnitz
Journal:  J Control Release       Date:  2016-02-28       Impact factor: 9.776

5.  Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.

Authors:  Evan M Chen; Amanda R Quijano; Young-Eun Seo; Christopher Jackson; Alexander D Josowitz; Seth Noorbakhsh; Andrea Merlettini; Ranjini K Sundaram; Maria Letizia Focarete; Zhaozhong Jiang; Ranjit S Bindra; W Mark Saltzman
Journal:  Biomaterials       Date:  2018-06-18       Impact factor: 12.479

Review 6.  Advances in nanomedicine for the treatment of ankylosing spondylitis.

Authors:  Yanhai Xi; Tingwang Jiang; Birendra Chaurasiya; Yanyan Zhou; Jiangmin Yu; Jiankun Wen; Yan Shen; Xiaojian Ye; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2019-10-29

7.  Controlled release of carnosine from poly(lactic-co-glycolic acid) beads using nanomechanical magnetic trigger towards the treatment of glioblastoma.

Authors:  Kinana Habra; Robert H Morris; Stéphanie E B McArdle; Gareth W V Cave
Journal:  Nanoscale Adv       Date:  2022-04-27

8.  Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization.

Authors:  Yoshitaka Okuda; Masanori Fukumoto; Taeko Horie; Hidehiro Oku; Shinji Takai; Toyofumi Nakanishi; Kaori Matsuzaki; Hiroyuki Tsujimoto; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2018-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.